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Abstract
Background: Rapid advancements in rehabilitation science and the widespread application of engineering
techniques are opening the prospect of a new phase of clinical and commercial maturity for Neuroengineering,
Assistive and Rehabilitation Technologies (NARTs). As the field enters this new phase, there is an urgent need to
address and anticipate the ethical implications associated with novel technological opportunities, clinical solutions,
and social applications.
Main idea: In this paper we review possible approaches to the ethics of NART, and propose a framework for ethical
design and development, which we call the Proactive Ethical Design (PED) framework.
Conclusion: A viable ethical framework for neuroengineering, assistive and rehabilitation technology should be
characterized by the convergence of user-centered and value-sensitive approaches to product design through a
proactive mode of ethical evaluation. We propose four basic normative requirements for the realization of this
framework: minimization of power imbalances, compliance with biomedical ethics, translationality and social
awareness. The aims and values of the CYBATHLON competition provide an operative model of this ethical
framework and could drive an ethical shift in neuroengineering and rehabilitation.
Keywords: Ethics of assistive technology, Proactive ethical design, User-centered, Value sensitive design,
Neuroethics, Cybathlon
Background
With rapid advancements in rehabilitation science and
the widespread application of engineering techniques for
the restoration, compensation, assistance and enhance-
ment of human neural systems, the field of neuroengi-
neering is entering a new phase of clinical and
commercial maturity. The first pioneering research
prototypes of the 1980s and 90s have evolved into an
increasingly mature technological spectrum with direct
clinical applications and corroborated efficacy. Over the
past two decades, assistive and rehabilitation technologies
have increased in number and variety. Concurrently, many
invasive and non-invasive neurotechnologies have become
available for assistive and rehabilitation aims. This
expanded technological domain might be regarded as
Neuroengineering, Assistive and Rehabilitation Technol-
ogy (NART). NARTs have been developed with the main
purpose of mitigating several morbidities associated with
diseases and traumatic injuries to the human nervous
system. Today, this evolving spectrum encompasses five
major technological families: devices for robot-assisted
training, functional electrical stimulation (FES) tech-
niques, prosthetics, brain-computer interfaces (BCIs) and
powered mobility aids, many of which were listed as
competing disciplines in the CYBATHLON 2016 [1].
Many of these applications have shown efficacy in
improving neurological care and neurorehabilitation in
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relation to a number of functional domains. For ex-
ample, randomized controlled trials performed on ro-
botic devices for post-stroke therapy and rehabilitation
showed that NARTs can enable significant improve-
ments in the therapeutic outcomes compared to usual
care [2], especially with respect to motor function [3]
and quality of life [4]. In parallel, at the commercial
level, several neuroengineering tools for assistance and
neurorehabilitation have made their way onto the
market and are now available as effective tools for
neurological care and rehabilitation. The InMotion
ARM™ robot, for instance, allows the efficient delivery of
personalized intensive sensorimotor therapy to neuro-
logic patients who need upper-limb rehabilitation while
the Lokomat® powered robotic gait trainer has shown ef-
fectiveness in improving locomotor gait-training for pa-
tients with incomplete spinal cord injury.
As the field of NART enters a new phase of clinical
and commercial maturity, many authors have urged to
address the ethical implications of this emerging field.
In a recent report based on the outcomes of a joint work-
shop between the US National Science Foundation and the
German Research Foundation on “New Perspectives in
Neuroengineering and Neurotechnology”, a group of inter-
national experts identified key technological, social and eth-
ical challenges to the adoption of NARTs in the clinical
setting. They concluded that the envisaged progress in neu-
roengineering requires a careful reflection on the ethical
and social implications, in particular in relation to issues
such as safety, security, privacy, public acceptance and re-
spect for autonomy [5]. In a similar fashion, participants of
an interdisciplinary symposium at the NeuroTechnology
Center (NTC) at Columbia University have advocated for
the integration of ethics into neurotechnology and recom-
mended the development of ethical guidelines for devel-
opers and users of novel products [6]. This need for ethical
guidelines has not been advocated only by researchers and
scientists but also by rehabilitation professionals. Nijboer
et al. have investigated the views of rehabilitation profes-
sionals and other stakeholders on the use of BCIs (one of
the six disciplines featured in the CYBATHLON 2016) as
assistive technologies. Their findings show that profes-
sionals are urging developers to carefully consider ethical
and socio-cultural issues at the level of design [7]. In
addition, the lack of ethical consideration is increasingly
seen as a major barrier for technology transfer of BCIs as
assistive technology in neurorehabilitation [8].
Although it has only recently become an object of em-
pirical and normative investigation, the need for ethical
analysis in clinical neuroengineering is not a new de-
mand but one that is deeply rooted in the neurorehabil-
itation practice. In fact, ethical significance is inherent to
the very objectives and mission of the neuroengineering
enterprise. As the goal of clinical neuroengineering and
neurorehabilitation is to restore, repair, assist and enhance
the capabilities of people with neurological conditions, its
very mission is of primary ethical relevance and implicitly
incorporates moral principles such as promoting end-
user’s autonomy, wellbeing and independence, empower-
ing them across a wide range of activities and reducing
their social isolation. This predominantly beneficence-
oriented and autonomy-oriented ethical goal is well cap-
tured by the mission of the Rehabilitation Engineering and
Assistive Technology Society of North America (RESNA).
RESNA’s mission statement, in fact, emphasizes the aim of
improving the potential of people with disabilities to
achieve their goals through the use of technology.1 An
ethics-laden language is also at core of the Cone Health
Neurorehabilitation Center, where a stroke support group
was recently established for newly diagnosed patients “to
make certain they feel empowered to take charge of their
health and wellness to live a full life”.2
In addition, the clinical implementation of NART
raises ethical attention because the end-user population
of these technologies is largely composed by vulnerable
individuals with neurological conditions and other func-
tional variabilities that, in virtue of their vulnerability,
are often entitled to extraordinary ethical protection. For
example, clinical BCIs can be used by individuals with
advanced neuromuscular disorders, including patients
with locked-in syndrome [9], while robot-aided rehabili-
tation provides effective support during the recovery
process of patients following a stroke [10].
Finally, as the pace of development of new techno-
logical products is reportedly faster than their social
adoption and ethico-legal assessment, there is a risk that
the beneficial potential of NART remains under-
expressed if social, ethical and legal implications remain
unaddressed. This is particularly relevant for potentially
disruptive sociotechnological trends such as assistive ro-
botics as well as for technologies ─such as invasive
BCIs─ that establish direct connection pathways with
the human brain, hence raising delicate ethical questions
about integrity, mental privacy and personhood [11]. A
recent review about responsibility in rehabilitation ro-
botics (including neurorehabilitation robots, robotic
prostheses, and even next-generation personal assistance
robots), has observed that most devices operate in close
proximity or direct physical contact with patients, ma-
nipulate instruments inside their bodies or directly move
their impaired limbs, and have invasive or non-invasive
connections with the human nervous system [12]. This
raises the need for high ethical attention. While there is
an increasing consensus among scientists, engineers and
clinicians that ethics is relevant for NART, several con-
ceptual and practical obstacles prevent the successful in-
corporation of ethical factors into product design and
development.
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First, at the conceptual level, it is often unclear what
ethical considerations should be prioritized and at what
level of the technology development process (e.g. design,
clinical trials, or post-commercialization assessment).
Second, at the practical level, ethical guidelines and
ethics-oriented clinical recommendations remain rare.
For example, the RESNA Strategic Plan 2014–2018 does
not address ethical considerations and even the RESNA
Code of Ethics provides only eight general integrity
guidelines to guide the conduct of members and service
providers but remains silent on how to incorporate eth-
ics into technology or how to maximize ethical values
through their applications.3 Similarly, the IEEE Engineer-
ing in Medicine and Biology Society (EMBS), the world’s
largest international society of biomedical engineers,
provides a set of rules for ethical conduct in research
but does not address substantive ethical considerations
associated with technology use. In other words, existing
guidelines often focus on how to ethically develop assist-
ive technologies. However, little guidance is available to
engineers and researchers on how to develop ethical as-
sistive technologies, that is technologies that promote
ethical values.
Third, in many assistive domains such as the support
and rehabilitation of elderly adults with physical or cog-
nitive disabilities, ethical design remains reportedly spor-
adic [13] while ethical assessment and compliance with
guidelines are often perceived by developers and manu-
facturers as delay factors in the process of development
and commercialization of new products.
In this paper we review possible approaches to the eth-
ics of NART and propose a framework for ethical design
and development, which we call the Proactive Ethical
Design (PED) framework. We also suggest that the aims
and values of the CYBATHLON [1] provide an ostensive
and operative model of this ethical framework.
It is important to highlight that the ethical challenges
raised by assistive and rehabilitation technology are not
necessarily unique but might apply also to other sectors
of medical technology. Nonetheless, the repeated calls
for ethical guidelines advocated by experts’ committees
and the relative infrequency of ethical guidelines in pro-
fessional codes indicate a need for a proactive and col-
laborative framework that could facilitate the successful
design, development and implementation of assistive
and rehabilitation technology in an ethically responsible
manner.
Reactive vs. proactive ethics of assistive
technology
The ethical aspects of NART can be approached either
reactively or proactively. Reactive approaches focus on
the critical ethical evaluations of novel products and the
assessment of their compatibility with existing normative
ethical principles. In reactive ethics, ethical conflicts or
problems are addressed as they arise, which usually oc-
curs only at the end of the development process when
the finished system is being implemented. For example,
authors have performed ethical assessment of commer-
cially available consumer-grade BCIs and argued that
their security vulnerabilities may conflict with the
principle of informational privacy [11, 14].
In contrast, proactive approaches are characterized by
the development of strategies and solutions before a new
technology becomes a source of potential ethical con-
frontation or conflict. Instead of merely reacting to an
existing ethical problem, proactive approaches anticipate
future potential uses, requirements, and unintended
consequences of new technologies before they become
ethical issues. For example, Bonaci et al. (2015) have an-
ticipated an operative solution to the privacy vulnerabil-
ity of commercial BCIs and developed a system called
BCI Anonymizer that integrates privacy safeguards into
the BCI headset [15], hence proactively promoting the
ethical principle of respect for privacy.
The notion of proactive ethics was independently
coined in the fields of, respectively, business ethics and
clinical ethics consultation. In business ethics, the notion
“proactive” is used when a business introduces ethical
measures (e.g. transparency, accountability and commu-
nication) before the eruption of crisis situations, rather
than in response to the crisis [16]. Similarly, in clinical
ethics consultation, this notion is used to describe a
process-oriented approach to ethics consultation (e.g. in
ICUs) where communication and planning begin prior
to crises [17]. Pavlish et al. (2013) have further devel-
oped this notion into a Proactive Ethics Framework, that
is a comprehensive set of proactive, ethics-specific, and
evidence-based strategies for mitigating ethical conflicts
in the clinical setting [18]. This framework included se-
quential key action points, beginning with the creation
of an ethics-minded culture, and continuing with the
implementation of risk reduction strategies and the re-
sponse to early indicators.
Reactive and proactive approaches are not necessarily
mutually exclusive but can be complementary. As the
example above shows, they can be two sequential phases
of a continuing technology assessment process: first, in
the reactive phase, ethical conflicts are identified and
assessed; concurrently, in the proactive phase, further
ethical considerations are anticipated and ethically rele-
vant solutions are incorporated into the design of novel
products.
The advantage of reactive approaches to the ethics of
neuroengineering is that they allow ethicists and engi-
neers to optimize their efforts and focus on concrete
problems rather than on the anticipation of possible fu-
ture scenarios that are often hard to foresee. However,
Ienca et al. Journal of NeuroEngineering and Rehabilitation  (2017) 14:115 Page 3 of 11
reactive approaches ─if not in conjunction with concur-
rent proactive considerations─ present several disad-
vantages. First, they are structurally postdated since they
provide ethical advice, by definition, only at the post-
development level [19], that is at a stage when there is
little or no room for modification of a NART device.
Second, in several domains of cognitive and physical dis-
ability such as dementia and age-dependent frailty, the
lack of proactive ethical and social considerations has
been inferred as a determinant of low adoption and ac-
ceptance of technology [20, 21]. In fact, if the impact of
ethically relevant factors is not anticipated, products
might not match the end-users’ needs and wishes, hence
result in sub-optimal uptake, implementation lag and
delayed clinical or social benefit. Third, there is a risk
that lack of proactive ethical considerations may cause
negative public perceptions or even unjustified Luddite
fears among end-users, caregivers and other relevant
stakeholders [22]. This risk is particularly concrete in re-
lation to advanced technologies such as those that in-
corporate or embed Artificial Intelligence, as their
underlying mechanisms and functionalities are often un-
clear to users [23]. Finally, reactive approaches are a pos-
sible source of antagonism and conflict between
designers and developers, on the one hand, and ethicists
and policy makers, on the other hand. The reason for
that stems from the fact that, in a reactive context, engi-
neers and ethicists may engage in a competitive dynamic
where the work of the former professionals is being con-
stantly questioned and judged by the latter. By contrast,
in a proactive approach, all parties are encouraged to
work together. It is worth considering, however, that
even though proactive approaches encourage interaction
among ethicists and engineers, they are not necessarily
conductive to collaborative approaches.
Modes of proactive ethics: User-centered and
value-sensitive design
In most circumstances, the type of approach to the eth-
ics of NART chosen by manufacturers is influenced by
the process of product design. For example, the increas-
ing prevalence of bottom-up and user-driven approaches
to the design of NARTs has been often observed to
“move a step further to the ethics of the user” [24], re-
duce usability problems or conflicts ─since these can be
identified and resolved before the systems are
launched─ and facilitate the incorporation of ethical
considerations in the design process [13]. This suggests
that the type of technological design adopted by manu-
facturers is not morally neutral but determines the pos-
sibilities of an assistive technology and has consequences
for human wellbeing [19].
The “user-centered” (sometimes also referred to as
“patient-centered”) approach is a framework of processes
for the design and development of assistive technologies
in which the needs, wishes, and limitations of end-users
are given extensive attention at each stage of the design
process [25] (Fig. 1). The user-centered (UC) family en-
compasses a number of methodologically contiguous ap-
proaches including cooperative design (where designers
and users are involved on an equal footing), participa-
tory design (where users are involved through active and
participative processes) and contextual design (where
the participatory process occurs in the actual context or
environment). For example, the Us’em wearable device,
a rehabilitation tool for motivating stroke patients to use
their impaired arm-hand in daily life activities, was de-
signed and developed using an user-centered process
during which stroke patients, therapists, rehabilitation
researchers, and interaction design experts were actively
involved [26].
UC approaches are being increasingly considered a ne-
cessary requirement for ethical design of NART [8, 27].
The reason for that is twofold.
First, by putting users at the center of design and devel-
opment, UC approaches shift the location of power in the
research process [28]. Through this approach, users are no
longer conceptualized as passive recipients of a new prod-
uct who are implicitly coerced to change their behavior to
accommodate the new technology. In contrast, they are
empowered at each stage of the design and development
process (requirement analysis, pre-production models,
mid-production and post-production). In addition, they
are no longer subordinated to designers in the
decision-making process regarding a new technology,
but actively involved in a cooperative dynamic and on a
potentially equal footing.
Second, at the practical level, UC approaches facilitate
the translation of new assistive technologies into standard
rehabilitation practice and care, hence accelerate and
maximize the social and clinical benefits of technological
innovation. In fact, the translation of new technologies
from the designing lab to the rehabilitation clinic can best
be accomplished if a patient-centered focus is incorpo-
rated throughout the research and development con-
tinuum and changes are made so that biomedical
innovation serves the broadest needs within the shortest
period of time [29]. This societal outcome is consistent
with multiple ethical principles and theories. For example,
it is consistent with Stuart Mill’s principle of aggregate
utility, the foundational ethical tenet of classic utilitarian-
ism, according to which people desire happiness —the
utilitarian end— and where general happiness is consid-
ered “a good to the aggregate of all persons” [30].
Third, in determining this shift in the location of power,
UC approaches inherently promote ethical principles, espe-
cially the respect for autonomy, which is one of the four
fundamental principles of biomedical ethics [31]. At least
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two components of personal autonomy are promoted
through UC design: decisional autonomy and executional
autonomy [32]. Decisional autonomy is the capability to
make decisions without restraint from other actors or pre-
imposed designs. This capability is promoted if users are
actively involved in the decisional process of product design
and enabled to make choices or suggestions based on their
wishes and needs. Executional autonomy is the capability
to act according to a desired course of action. This capabil-
ity is promoted if users can successfully use assistive tech-
nologies tailored around their needs and wishes, hence
become able to perform tasks that they might not be able
to perform otherwise.
However, authors have argued that decisional and
executional autonomy might not be sufficient to guaran-
tee full autonomy and participation of users in rehabili-
tation. Rather, another component of the autonomy
concept is required, that is self-realization [32]. Accord-
ing to this notion, users should not only be granted the
capability to make free decisions and act independently,
but should also be able to shape their life “into a mean-
ingful existence which expresses individuality” (p. 972).
Patients who need NARTs may be experiencing a
reduction in their capacity to act as autonomous persons
along all these three dimensions (decisional, executional
and self-realization). Therefore, NARTs may compensate
for such reduced capacity and boost patient autonomy.
Considerations of this kind have led researchers to
complement the user-centered framework with values of
psychological and ethical significance. The resulting sys-
tematic approach is called value-sensitive design (VSD)
and is characterized by the embedment of human values
into technology design. In the VSD approach values are
defined as the “principles or standards of a person or so-
ciety, the personal or societal judgment of what is valu-
able and important in life” [33].
According to the VSD approach, NARTs should em-
body and account for ethical, social and psychological
values “through a theoretically grounded approach in a
principled and comprehensive manner throughout the
design process” [34]. VSD has often been described by
engineers, clinicians and ethicists as a successful strategy
to incorporate ethics in the overall design process of as-
sistive and rehabilitation technology [19, 35]. In light of
this, VSD approaches have raised increasing interest
among researchers, a phenomenon confirmed by a
Fig. 1 A Visual Representation of the Iterative Dynamics of User-Centered Design
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fivefold increase in research papers in the field of
human-computer interaction mentioning “human
values” during the past ten years [36].
Recently, ethicists of healthcare technology have tried to
operationalize the principles of VSD in the context of as-
sistive and rehabilitation technology. For example, van
Wynsberghe has used the blueprint of VSD “as a means for
creating a framework tailored to care contexts”. These ef-
forts are motivated by the need of guaranteeing that NARTs
enter the clinical domain in a manner that “supports and
promotes fundamental values” in healthcare [35].
While having the merit of enhancing the ethical sensi-
tivity of emerging assistive technology, neither the UC
nor the VSD approach are anchored by default on a spe-
cific normative grounding or ethical theory [37]. Rather,
they can be realized through multiple normative princi-
ples or ethical theories. In addition, it has been observed
that differences exist between designers’ values and
users’ values [38]. This raises the question of how to im-
plement VSD approaches in a multi-cultural society
where people could reasonably disagree on important
values. While we recognize the importance of the prob-
lem, in this paper we refer to VSD as a method “that can
be applied in principle to any set of values” and not as
the “methodological instantiation of a particular set of
values” [36]. Future ethical research should discuss
which ethical values (e.g. universal vs. culturally-relative)
should actually be instantiated in NARTs.
While we remain agnostic about the specific instanti-
ation of ethical values in the strong sense, in the follow-
ing, we propose a UC and VSD approach to ethical
assistive and rehabilitation technology based on four
basic normative requirements. We call this approach the
Proactive Ethical Design (PED) framework. Finally, we
refer to the experience of the CYBATHLON 2016 com-
petition as an ostensive and operative model of this eth-
ical framework.
A framework for proactive ethical design
There is an increasing consensus that UC and VSD are
necessary requirements for ethically sustainable develop-
ment of assistive and rehabilitation technology [7, 8, 13].
However, little analysis is available on the prerequisites
of successful adoption of such approaches. Based on the
inherent goals and objectives of UC and VSD described
above, we argue that four basic normative requirements
are necessary for the successful implementation of eth-
ical NART.
Minimization of power imbalances
Both UC and VSD presuppose the minimization of
power imbalances in decision-making and a certain de-
gree of inclusiveness and democratization in the design
process. This shift in the location of power across the
technology design continuum is best achieved through a
goal-oriented cooperation among designers, developers
and end-users. This principle implies that in order to be
involved on an equal footing in the design process, all
stakeholders should be incentivized to share common
goals that could be pursued through coordinated and co-
operative efforts. In fact, in absence of common goals or
even in presence of mutually conflicting objectives be-
tween different stakeholders (e.g. designers vs users), no
successful cooperation within the UC and VSD frame-
work is likely to occur. An example of conflicting objec-
tives between different stakeholders is the observation
that designers and developers often prioritize the effect-
iveness of a new technology whereas users often
prioritize usability. Effectiveness refers to the accuracy
and completeness with which end-users can achieve cer-
tain goals in a certain environment. Usability is the easi-
ness and extent to which a technology can be used by
users to effectively achieve these goals. This discrepancy
between effectiveness and usability has been particularly
investigated in the context of assistive BCI, one of the
technologies featured in the CYBATHLON 2016 [1]. For
example, a review of BCIs as access pathways for people
with severe disabilities has shown that most current pro-
totypes are developed with focus on speed and accuracy
instead of usability [39]. These conflicts of objectives can
have detrimental consequences for rehabilitation as they
could concur in the phenomenon of technology aban-
donment. This refers to the fact that users of an avail-
able assistive or rehabilitation technology might stop
using it after an initial phase, a phenomenon that is par-
ticularly common with technologies for home use.
Scherer has reported that about one third of all assistive
technologies are abandoned, and many others might
continue to be used sub-optimally due to unease and
discomfort. As she states: “we have no information about
the number of people who continue to use devices they
are unhappy or uncomfortable with because they cannot
abandon them without facing more severe conse-
quences” [40]. In addition, the absence of common ob-
jectives among different stakeholders involved in the
design and development of assistive and rehabilitation
technologies is likely to cause the so-called “problem of
many hands” [41]. This problem denotes the risk that in
complex process where multiple stakeholders are ac-
tively involved errors can be made although no class of
stakeholders acted in an explicitly reckless or negligent
way.
To overcome this problem, there is a need for har-
monizing the objectives of all relevant stakeholders in-
volved in the design process through an iterative and
dialogic confrontation. This could be achieved by creat-
ing cooperative scenarios where all stakeholders are in-
centivized to pursue a common goal or objective.
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Compliance with biomedical ethics
The second requirement for the successful implementa-
tion of ethical assistive technology in rehabilitation is
compliance and coherence with biomedical ethics.
NARTs are integral part of biomedicine and biotechnol-
ogy. Nonetheless, their degree of ethical scrutiny by bio-
medical ethicists is often lower compared to other
domains of biomedicine and biotechnology such as
pharmacological interventions. This is probably due to
many factors including the relative novelty of NART, a
less stratified history of misuse and different risk-related
perceptions among professionals.
We argue that successful technology development via
UC and VSD presupposes the compliance with biomed-
ical ethics. As we said before, this requirement can be
fulfilled through compliance with multiple approaches
and values in biomedical ethics such as utilitarianism,
Kantianism or virtue ethics. Among others, one viable
and, according to some, easy-to-implement approach is
principlism, a practical approach for ethical decision-
making that focuses on four common-ground moral
principles: beneficence, non-maleficence, autonomy and
justice. Research shows that the principlist approach has
the largest circulation among health professionals and
the highest prevalence in ethics curricula for health sci-
ence students [42, 43]. This fact could, ceteris paribus,
guarantee better acceptance and easier implementation
among health professionals. However, it is important to
highlight that, at any rate, referring to any specific eth-
ical theory in a predetermined manner risks to preempt
normative input from users. Therefore, it is important
that, at any rate, ethical theories or principles are chosen
based on the needs and values of users, and adapted to
these needs and values through an iterative and flexible
process. In other words, the investigation of the users’
needs and values should determine which ethical con-
tent is most suitable for a certain technology in a certain
patient population, not vice versa.
Principlism, uses a “common morality” approach and
“mid-level” prima facie principles: beneficence, non-
maleficence, respect for autonomy and justice [31]. Ben-
eficence is the promotion of the wellbeing of people with
disability through the successful implementation of as-
sistive and rehabilitation technology. As we have seen
above, the field of assistive and rehabilitation technology
urges a broad concept of beneficence that is not only fo-
cused on the effectiveness of new technologies but also
on their usability.
Non-maleficence is the principle of preventing or min-
imizing harms associated with the use of assistive and
rehabilitation technology. This principle is promoted
through the implementation of safeguards for the safe
and secure use such as the precautionary approach,
namely the idea that technologies whose consequences
are difficult to predict should be first investigated in a
safe setting [19]. Neurorehabilitation experts have tried
to systematize the principle of non-maleficence in rela-
tion to robot-assisted neurorehabilitation [44]. Their
model is based on the postulation of three fundamental
laws called the laws of neurorobotics in rehabilitation, a
re-elaboration of Asimov’s laws of robotics [45]:
(I) A robot for neurorehabilitation may not injure a
patient or allow a patient to come to harm.
(II)A robot must obey the orders given it by therapists,
except where such orders would conflict with the
First Law.
(III)A robot must adapt its behavior to patients’ abilities
in a transparent manner as long as this does not
conflict with the First or Second Law.
The first law postulates that rehabilitation robotics
should be safe not only in terms of movement, but
also from other medical points of view. This can be
achieved by designing new products in accordance
with international standards such as ISO 13482:2014
[46] and through careful consideration of unintended
harms, where harm is understood as any “possible
damage to patients” including discomfort and time
spent on ineffective rehabilitation. The second law
postulates that assistive technologies should not re-
place therapists, but rather complement existing treat-
ment options. Therapists should always be on the
loop of robot-assisted rehabilitation and maintain a
position of control in relation to the adjustment of
technological parameters, the avoidance of harmful
compensation strategies and identification of trade-
offs between rehabilitative goals and the psychological
dimension of patients. Risks of reduced control over
technological parameters such as is the discrepancy
between the desired and actual values of some param-
eters of the electromechanical Gait Trainer [47]
should be prevented. At the same time, based on the
third law, automatic features and artificial intelligence
might be used to support rehabilitation therapists by
performing all the control changes required for a suc-
cessful therapy.
The principle of respect for personal autonomy, as
stated above, should not be seen exclusively as the pro-
motion of decisional and executional autonomy, but of
self-realization as well. To achieve that, UC approaches
should not only involve the active participation of end-
users and investigate their perceptions only in relation
to quantitative parameters such as effectiveness and us-
ability, but should proactively incorporate user-driven
ethical and psychological factors in product design.
Given the requirements of context-sensitive design, this
attempt to “materializing morality” [48] through assistive
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technology should be dependent on the specific context
and environment of end-users.
Finally, justice is the principle of biomedical ethics that
requires assistive technologies to be fairly accessible to
users, affordable across various socioeconomic classes,
and evenly distributed across rehabilitation clinics in
various world regions. While this principle can be incor-
porated into product design by favoring scalable, low-
cost and pervasive technologies, yet design alone might
be insufficient. In addition to that, justice-promoting
policies should be pursued at various levels of health-
technology regulation. Reimbursement policies and State
incentives have been advocated elsewhere as possible
justice-promoting regulatory interventions [27].
Translationality
The third requirement is translationality. In fact, the eth-
ical goal of maximizing wellbeing for all individuals with
disability through the use of NART is highly dependent
on the process of translating research from the designing
lab to the rehabilitation center. In order to maximize the
societal benefits of NART, we need to ensure that new
technologies actually reach the patients or population
for whom they are intended and are implemented cor-
rectly [49]. Slow or incomplete translation across bench,
bedside and community ─ which the European Society
for Translational Medicine calls the “three main pillars”
─ is likely to reduce the beneficial impact of assistive
technology on the global healthcare system. According
to the Institute of Medicine’s Clinical Research Roundta-
ble, two distinct phases in the translational process are
in particular need of improvement: the first translational
block (T1) prevents basic research findings from being
tested in a clinical setting; the second translational block
(T2) prevents proven interventions from becoming
standard practice.4
Social awareness
Finally, the fourth requirement is raising social aware-
ness and favoring knowledge dissemination across soci-
ety. The public is often skeptical or reluctant regarding
the use of new technologies because of lacking know-
ledge on the technology and its applications [50]. Sociol-
ogists have identified historical patterns and dynamics of
opposition to technological innovation. For example,
Juma has explored the multi-layered dimensions of socio-
political resistance to various types of technological
innovation including biomedical technology. These in-
clude established social norms, financial considerations,
health implications, social disruption, as well as prejudices
or human ignorance [50]. Patterns of resistance to new
technologies have also been observed in the specific con-
text of healthcare technology [51]. This opposition seems
to be particularly significant in relation to technologies
that operate in proximity to the human body such as
wearable devices and neural prosthetics. A 2014 Pew sur-
vey showed that 53% of Americans think it would be a
bad thing if “most people wear implants or other devices
that constantly show them information about the world
around them.” In contrast, just over one third (37%) think
this would be “a change for the better” [52]. Since many
NARTs operate in close proximity or direct physical con-
tact with patients, and have invasive or non-invasive con-
nections with the human nervous system, they are likely
to be affected by these negative public perceptions.
The media, a major catalyzer of attention and know-
ledge on novel technological possibilities, have started
only recently to properly cover the domain of neuroengi-
neering, assistive and rehabilitation technology. Concur-
rently, since NARTs are still in an initial phase of the
technology life cycle, their pervasive implementation
might still be limited by enduring habits of health pro-
fessionals, financial limitations and issues of resource al-
location or conservative managerial decisions ─all
phenomena that have already been observed in other
sectors of healthcare technology [53–55]. If improving
the effectiveness, usability and ethical potential of assist-
ive technology is the grand challenge for neuroengineer-
ing, raising social awareness is the corresponding
societal challenge. It is worth stressing that these re-
quirements should not be seen as values per se, but as
conditions of possibility for the consideration and incorp-
oration of values through UC and VSD (see Fig. 2). In
fact, we hypothesize that UC and VSD approaches can-
not be properly implemented if: (i) major power imbal-
ances persist, (ii) biomedical ethics is ignored, (iii)
prototypes are not adequately translated into viable
products for users and (iv) there is a lack of social
awareness about the clinical benefits. However, we
recognize that this causal relationship can be bidirec-
tional as: (i) the four normative requirements enable UC
& VSD, but, in parallel, (ii) the adequate realization of
UC & VSD guarantees the fulfillment of the four norma-
tive requirements.
Proactive ethical design: The Cybathlon lesson
In October 2016, ETH Zurich organized in Zur-
ich, Switzerland, the first edition of the CYBATHLON,
an international championship for competitors with
disabilities using bionic assistive technologies. The com-
petition featured six disciplines – a Functional Electrical
Stimulation (FES) bicycle race, a Powered Leg Prosthesis
Race, a Powered Wheelchair Race, a Powered Exoskel-
eton Race, a Powered Arm Prosthesis Race, and a BCI
neurogaming race [1].
We argue that this innovative event represents an os-
tensive and operative model of the ethical framework de-
lineated in this paper. The reason for that stems from
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the fact that the CYBATHLON embodies all four re-
quired approaches for the successful implementation of
ethical NART in rehabilitation.
First, the CYBATHLON model fulfills the first require-
ment by providing an ideal setting for a goal-oriented
cooperation among different stakeholders. During the
CYBATHLON 2016 competition, designers, developers
and end-users have not only engaged in cooperative dy-
namics on an equal footing (as required by the UC ap-
proach) but also shared a common goal. This created a
goal-converging dynamic where the success in the race
of the user (the competing athlete) corresponds to the
success of the designing team. Such gamification creates
a fruitful and possibly reproducible setting for harmoniz-
ing the objectives of all relevant stakeholders involved in
the design process. Concurrently, it shifts the location of
power by putting the user (the individual athlete with
disability) at the center of the arena. This centrality of
the user in the competition is an ultimate form of em-
powerment: instead of being a passive recipient of
technology-assisted rehabilitation, the person with dis-
ability becomes the protagonist of a cooperative process.
Second, the CYBATHLON model fulfills the second
requirement by proactively anticipating compliance and
coherence with the principles of biomedical ethics. The
day prior to the competition, a roundtable discussion in-
volving end-users, patient and industry representatives
also hosted a prominent ethics researcher. In addition,
the creation of a goal-oriented cooperation between de-
signers and athletes facilitates the promotion of benefi-
cence, non-maleficence and patient autonomy by giving
them the possibility to request adaptations of the
prototypes according to their wishes and needs at every
stage of the process. This iterative process of needs as-
sessment and product adjustment exemplifies the ideal
feedback-loop between designers and users that should
be pursued in the research setting according to the UC
and VSD frameworks. While beneficence is captured by
the need of increasing efficiency, effectiveness and us-
ability in order to win the competition, and the non-
maleficence principle is embodied by safety-enhancing
safeguards, the autonomy of users is maximized by their
physical and decisional centrality in the process. As a
factor of limitation, the justice principle occurred more
sporadically during the CYBATHLON 2016 due to mul-
tiple facts: (i) high-performing technologies are likely to
be financially expensive; (ii) the competition took place
in one of the world’s wealthiest countries; (iii) most
competing teams were from affluent and highly industri-
alized nations. Future editions of the competition should
compensate for this omission and incorporate the justice
principle, for example by creating a component of the
competition involving low-cost technologies, hosting the
event in non-European and non-North American coun-
tries and encouraging participation of research teams
from emergent and developing countries.
Third, the CYBATHLON competition fulfills the
translationality requirement by enabling a smooth and
accelerated translation of innovative research in assistive
technology for the benefit of individual users and the
community. Each competing team in the CYBATHLON
championship is a small-scale translational round-block
that translates research findings into utilizable technol-
ogy and assesses them in a public arena together with
real end-users. This translational power is corroborated
by the possibility that through the CYBATHLON com-
petition many technologies originally designed for a
small-sized group of people with disability may found an
application in larger markets including people with simi-
lar functional disabilities or even able-bodied people.
From a business perspective, this possibility, jointly with
the commercial relevance of the CYBATHLON, could
expand the market of assistive technologies from a
small-scaled niche that creates little incentives for the
industry to pull the technology onto the market into a
broader, more mature and pervasive domain of techno-
logical innovation.
Finally, the surprising media coverage and societal at-
tention raised by the CYBATHLON 2016 could become
a critical catalyzer to raising social awareness on disabil-
ity and assistive technological solutions. Several inter-
national media including the British BBC, the German
Deutschlandfunk, the Swiss SRF, and the Canadian CTV
provided live coverage and subsequent analysis of the
competition. This degree of international coverage in
mainstream media could be a ground-breaker in the
Fig. 2 A Framework for the Proactive Ethical Design (PED) of
Neuroengineering, Assistive & Rehabilitation Technology
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effort of raising social attention and awareness about
novel technological possibilities in rehabilitation. In
addition, the possibility of watching real-time successful
applications of current assistive technologies may con-
tribute in changing negative societal perceptions on
these products and disseminate information and know-
ledge about this ever evolving technological domain
across society.
Conclusion
As the fields of assistive technology and neuroengineer-
ing are entering a new phase of clinical and commercial
maturity, there is an increasing need to address the eth-
ical implications associated with the design and develop-
ment of novel assistive and rehabilitative technological
solutions. After reviewing various ethically-sensitive ap-
proaches to the design of NART, we proposed a frame-
work for ethical design and development, which we call
the Proactive Ethical Design (PED) framework. This
framework is characterized by the convergence of user-
centered and value-sensitive approaches to product de-
sign through a proactive mode of ethical evaluation.
Four basic normative requirements are necessary for the
realization of this framework: minimization of power im-
balances, compliance with biomedical ethics, translation-
ality and social awareness.
Cooperative efforts of researchers, end-users, clinicians
and societal stakeholders are necessary to drive assistive
and rehabilitation technology towards the PED frame-
work and maximize the benefits of NART for individual
users and society at large. The innovative paradigm of
the CYBATHLON competition provides a promising op-
erative model of this ethical framework and could drive
an ethical shift in neuroengineering and rehabilitation.
In fact, the CYBATHLON establishes a platform for ex-
change and cooperation among various stakeholders in-
cluding people with disabilities, researchers, developers,
funding actors, media and the general public. In
addition, it encourages a convergence of goals between
researchers and end-users, promotes compliance with
ethical considerations, facilitates successful translation of
new technology and raises social awareness on assistive
technology and disability.
Endnotes




ethics (last accessed: 02/19/2017).
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